richard c mulligan born american scientist mallinckrodt professor genetics harvard medical director harvard gene therapy initiative visiting scientist koch institute integrative cancer research massachusetts institute also head sanax sana biotechnology mulligan started career gene therapy undergraduate biology alexander richs lab mit involved early work controlling gene expression using would earn phd biochemistry stanford university working paul berg develop viral vectors express human bacterial would postdoctoral training center cancer research mit david baltimore phillip sharp would join faculty molecular biology member whitehead institute biomedical time founding member recombinant dna advisory committee rac joined childrens hospital harvard become director harvard gene therapy initiative investigator howard hughes medical mulligan active investor founding partner senior managing director sarissa capital management along alex denner worked together carl would join icahn capital portfolio manager serves director enzon pharmaceuticals biogen idec httpsenwikipediaorgwikirichardcmulligan